Abstract
Purpose
To report technical feasibility and clinical efficacy of iliac vein stent placement in adolescent patients with May–Thurner Syndrome (MTS).
Materials and Methods
Single-institution retrospective review of the medical record between 2014 and 2021 found 63 symptomatic patients (F = 40/63; mean age 16.1 years, 12–20 years) who underwent left common iliac vein (LCIV) stent placement for treatment of LCIV compression from an overriding right common iliac artery, or equivalent (n = 1, left IVC). 32/63 (50.7%) patients presented with non-thrombotic iliac vein lesions (NIVL). 31/63 (49.2%) patients presented with deep vein thrombosis of the lower extremity and required catheter-directed thrombolysis after stent placement (tMTS). Outcomes include technically successful stent placement with resolution of anatomic compression and symptom improvement. Stent patency was monitored with Kaplan–Meier analysis at 3, 6, 12, 24, and 36 months. Anticoagulation and antiplatelet (AC/AP) regimens were reported.
Results
Technical success rate was 98.4%. 74 bare-metal self-expanding stents were placed in 63 patients. Primary patency at 12, and 24-months was 93.5%, and 88.9% for the NIVL group and 84.4% and 84.4% for the tMTS group for the same period. Overall patency for the same time intervals was 100%, and 95.4% for the NIVL group and 96.9%, and 96.9% for the tMTS group. Procedural complication rate was 3.2% (2/63) with no thrombolysis-related bleeding complications. Clinical success was achieved in 30/32 (93.8%) and 29/31 (93.5%) patients with tMTS and NIVL groups, respectively.
Conclusion
CIV stent placement in the setting of tMTS and NIVL is technically feasible and clinically efficacious in young patients with excellent patency rates and a favorable safety profile.
Similar content being viewed by others
References
Brinegar KN, Sheth RA, Khademhosseini A, et al. Iliac vein compression syndrome: clinical, imaging and pathologic findings. World J Radiol. 2015;7:375–81. https://doi.org/10.4329/wjr.v7.i11.375.
Warad DM, Rao AN, Bjarnason H, Rodriguez V. Clinical outcomes of May–Thurner Syndrome in pediatric patients: a single institutional experience. TH Open Companion J Thromb Haemost. 2020;4:e189–96. https://doi.org/10.1055/s-0040-1714694.
Ahmed O, Ng J, Patel M, et al. Endovascular stent placement for May–Thurner syndrome in the absence of acute deep vein thrombosis. J Vasc Interv Radiol. 2016;27:167–73. https://doi.org/10.1016/j.jvir.2015.10.028.
Mahnken AH, Thomson K, De Haan M, O’Sullivan GJ. CIRSE standards of practice guidelines on iliocaval stenting. Cardiovasc Intervent Radiol. 2014;37:889–97. https://doi.org/10.1007/s00270-014-0875-4.
Mousa AY, AbuRahma AF. May–Thurner syndrome: update and review. Ann Vasc Surg. 2013;27:984–95. https://doi.org/10.1016/j.avsg.2013.05.001.
Ibrahim W, Al Safran Z, Hasan H, Zeid WA. Endovascular management of May–Thurner Syndrome. Ann Vasc Dis. 2012;5:217–21. https://doi.org/10.3400/avd.cr.12.00007.
Moudgill N, Hager E, Gonsalves C, et al. May–Thurner syndrome: case report and review of the literature involving modern endovascular therapy. Vascular. 2009;17:330–5. https://doi.org/10.2310/6670.2009.00027.
Gaballah M, Shi J, Kukreja K, et al. Endovascular thrombolysis in the management of iliofemoral thrombosis in children: a multi-institutional experience. J Vasc Interv Radiol. 2016;27:524–30. https://doi.org/10.1016/j.jvir.2015.12.753.
Carr S, Chan K, Rosenberg J, et al. Correlation of the diameter of the left common iliac vein with the risk of lower-extremity deep venous thrombosis. J Vasc Interv Radiol. 2012;23:1467–72. https://doi.org/10.1016/j.jvir.2012.07.030.
Chan KT, Tye GA, Popat RA, et al. Common iliac vein stenosis: a risk factor for oral contraceptive-induced deep vein thrombosis. Am J Obstet Gynecol. 2011;205:537.e1-537.e6. https://doi.org/10.1016/j.ajog.2011.06.100.
Lungren MP, Ward TJ, Patel MN, et al. Endovascular thrombolysis to salvage central venous access in children with catheter-associated upper extremity deep vein thrombosis: technique and initial results. J Thromb Thrombolysis. 2015;40:274–9. https://doi.org/10.1007/s11239-015-1209-3.
Hartung O, Otero A, Boufi M, et al. Mid-term results of endovascular treatment for symptomatic chronic nonmalignant iliocaval venous occlusive disease. J Vasc Surg. 2005;42:1138–43. https://doi.org/10.1016/j.jvs.2005.08.012.
Ye K, Lu X, Li W, et al. Long-term outcomes of stent placement for symptomatic nonthrombotic iliac vein compression lesions in chronic venous disease. J Vasc Interv Radiol. 2012;23:497–502. https://doi.org/10.1016/j.jvir.2011.12.021.
Kwak H-S, Han Y-M, Lee Y-S, et al. Stents in common iliac vein obstruction with acute ipsilateral deep venous thrombosis: early and late results. J Vasc Interv Radiol. 2005;16:815–21.
Goldenberg NA, Branchford B, Wang M, et al. Percutaneous mechanical and pharmacomechanical thrombolysis for occlusive deep vein thrombosis of the proximal limb in adolescent subjects: findings from an institution-based prospective inception cohort study of pediatric venous thromboembolism. J Vasc Interv Radiol. 2011;22:121–32. https://doi.org/10.1016/j.jvir.2010.10.013.
Gill AE, Patel KN. The role of interventional radiology in the treatment of acute thrombosis and chronic veno-occlusive disease in children and adolescents. Semin Roentgenol. 2019;54:324–36. https://doi.org/10.1053/j.ro.2019.06.003.
Bozkaya H, Cinar C, Ertugay S, et al. Endovascular treatment of iliac vein compression (May–Thurner) Syndrome: angioplasty and stenting with or without manual aspiration thrombectomy and catheter-directed thrombolysis. Ann Vasc Dis. 2015;8:21–8. https://doi.org/10.3400/avd.oa.14-00110.
Gong M, Fu G, Liu Z, et al. Rheolytic thrombectomy using an AngioJet ZelanteDVT catheter or a solent omni catheter for patients with proximal vein thrombosis. Thromb J. 2023;21:25. https://doi.org/10.1186/s12959-023-00472-9.
Vedantham S, Kahn SR, Goldhaber SZ, Comerota AJ, Parpia S, Meleth S, Earp D, Williams R, Sista AK, Marston W, Rathbun S, Magnuson EA, Razavi MK, Jaff MR, Clive K. Endovascular therapy for advanced post-thrombotic syndrome: proceedings from a multidisciplinary consensus panel. Vasc Med. 2016;21(4):400–7.
Goldman RE, Arendt VA, Kothary N, et al. Endovascular management of May–Thurner Syndrome in adolescents: a single-center experience. J Vasc Interv Radiol. 2017;28:71–7. https://doi.org/10.1016/j.jvir.2016.09.005.
Bondarev S, Keller EJ, Han T, et al. Predictors of disease recurrence after venoplasty and stent placement for May–Thurner Syndrome. J Vasc Interv Radiol. 2019;30:1549–54. https://doi.org/10.1016/j.jvir.2019.07.012.
Craig P, Zuchowski A, Young S, et al. Results of endovascular management of May–Thurner syndrome in the acute, subacute, and chronic setting. J Vasc Interv Radiol. 2017;28:S113. https://doi.org/10.1016/j.jvir.2016.12.869.
O’Sullivan GJ, Semba CP, Bittner CA, et al. Endovascular management of iliac vein compression (May–Thurner) Syndrome. J Vasc Interv Radiol. 2000;11:823–36. https://doi.org/10.1016/S1051-0443(07)61796-5.
Murphy EH, Davis CM, Journeycake JM, et al. Symptomatic ileofemoral DVT after onset of oral contraceptive use in women with previously undiagnosed May–Thurner Syndrome. J Vasc Surg. 2009;49(3):697–703. https://doi.org/10.1016/j.jvs.2008.10.002.
Sayed MH, Salem M, Desai KR, et al. A review of the incidence, outcome, and management of venous stent migration. J Vasc Surg Venous Lymphat Disord. 2022;10:482–90. https://doi.org/10.1016/j.jvsv.2021.07.015.
Hacquebord JH, Leopold SS. In brief: the risser classification: a classic tool for the clinician treating adolescent idiopathic scoliosis. Clin Orthop. 2012;470:2335–8. https://doi.org/10.1007/s11999-012-2371-y.
Attaran RR, Ozdemir D, Lin I-H, et al. Evaluation of anticoagulant and antiplatelet therapy after iliocaval stenting: factors associated with stent occlusion. J Vasc Surg Venous Lymphat Disord. 2019;7:527–34. https://doi.org/10.1016/j.jvsv.2019.01.058.
Milinis K, Thapar A, Shalhoub J, Davies AH. Antithrombotic therapy following venous stenting: international delphi consensus. Eur J Vasc Endovasc Surg. 2018;55:537–44. https://doi.org/10.1016/j.ejvs.2018.01.007.
Arendt VA, Mabud TS, Kuo WT, et al. Comparison of Anticoagulation regimens following stent placement for nonthrombotic lower extremity venous disease. J Vasc Interv Radiol. 2021;32:1584–90. https://doi.org/10.1016/j.jvir.2021.08.016.
Neglén P, Hollis KC, Olivier J, Raju S. Stenting of the venous outflow in chronic venous disease: long-term stent-related outcome, clinical, and hemodynamic result. J Vasc Surg. 2007;46:979-990.e1. https://doi.org/10.1016/j.jvs.2007.06.046.
Gwozdz AM, Doyle AJ, Hunt BJ, et al. Effect of thrombophilia on clinical outcomes of chronic post-thrombotic patients after iliofemoral stenting with nitinol venous stents. J Vasc Surg Venous Lymphat Disord. 2021;9:888–94. https://doi.org/10.1016/j.jvsv.2020.09.013.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have collectively agreed upon the submission to Cardiovascular and Interventional Radiology (CVIR). The authors report no conflicts of interest relevant to the nature of the study. No funding was received to produce this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bertino, F.J., Hawkins, C.M., Woods, G.M. et al. Technical Feasibility and Clinical Efficacy of Iliac Vein Stent Placement in Adolescents and Young Adults with May–Thurner Syndrome. Cardiovasc Intervent Radiol 47, 45–59 (2024). https://doi.org/10.1007/s00270-023-03628-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-023-03628-2